In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Paul Royalty buys share of Rotarix royalties from CCHMC

Executive Summary

The Paul Royalty Fund has bought a share of the royalties owed to three researchers at the Cincinnati Children's Hospital Medical Center from GlaxoSmithKline for GSK's worldwide sale of Rotarix, an oral vaccine against rotavirus that the researchers originally helped develop.
Deal Industry
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Royalty Sale

Related Companies